Eiro exists because depression treatment shouldn't be guesswork.
We're a health technology company building prediction tools to end trial-and-error depression care. Born from research. Built to make a difference.
Where we come from
Eiro emerged from research at Vanderbilt University and Vanderbilt University Medical Center as part of the Wellcome Leap MCPsych program — a $50M global initiative focused on transforming the treatment of depression through data and technology.
The problem we set out to solve is straightforward: depression has many effective treatments, but no reliable way to match a given patient to the one most likely to work for them. The result is months or years of trial and error that compounds suffering and drives up costs.
This is a solvable problem. It requires the right data, the right models, and the rigor to get it right.
What we're building
Eiro is building FDA-regulated software — Software as a Medical Device (SaMD) — to predict treatment response in depression. This isn't a chatbot, a therapy app, or a wellness platform. It will be a clinical decision support designed to help clinicians and patients make better-informed treatment choices.
Building this requires real-world data at a scale that doesn't exist yet. Eiro Engage is how we're getting there — working directly with people to document their treatment journeys and assemble the dataset that will power these predictions.
How we think about this work
Rigor over speed
We're pursuing FDA clearance because this technology needs to be held to a high standard. Prediction models that influence treatment decisions have to be safe and effective. We're building carefully because the stakes demand it.
Data is the bottleneck
The limiting factor in building depression treatment prediction isn't algorithms — it's data. The datasets that would make this possible don't exist yet. That's why our first product is a data collection platform, not a prediction tool.
Built with people, not just for them
The people who contribute data through Eiro Engage aren't study subjects. They're collaborators. They're compensated for their time, they control their data, and they're building something that will help people like them in the future.
Honest about what's hard
We're not claiming we've solved depression. We're working on a specific, tractable problem — treatment selection — and we're transparent about where we are in that process and what remains to be done.
The team
Eiro was founded by people who've spent years working at the intersection of data systems, clinical research, and regulated technology.
Interested in contributing?
Learn how Eiro Engage works and whether you're eligible to participate.
Learn about Eiro Engage →